CASI Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CASIF | CRIS | PCSA | CHRS | HBP.TO | ALXO | |
|---|---|---|---|---|---|---|
| Market cap | 2.06M | 7.41M | 5.41M | 131.36M | 70.27M | 188.06M |
| P/E (TTM) | — | 0.8 | — | — | — | — |
| Forward P/E | — | -0.2 | -0.5 | -1.3 | -8.4 | -2.5 |
| Price/book | 0.0 | 0.5 | -17.0 | 2.2 | 4.8 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −91.85% | −97.50% | −77.18% | −42.95% | −54.68% | +15.25% |
| Today | −9.09% | +55.48% | −0.26% | +5.54% | 0.00% | +5.43% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CASIF news ›CASI Pharmaceuticals (NASDAQ:CASI) versus Organon & Co. (NYSE:OGN) Head to Head Survey
Posted by Tristan Rich on Oct 31st, 2026 Organon & Co. (NYSE:OGN – Get Free Report) and CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two…
Critical Survey: CASI Pharmaceuticals (NASDAQ:CASI) versus Theravance Biopharma (NASDAQ:TBPH)
Posted by Kim Johansen on Oct 12th, 2026 CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) and Theravance Biopharma (NASDAQ:TBPH – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.